Enter your search term below:
June 1, 2026 – The International Society for Cell & Gene Therapy (ISCT) is delighted to announce the appointment of Jaap Jan Boelens, MD, PhD, as the inaugural ISCT Chief Medical Officer, effective June 1st, 2026 through December 31, 2028. Dr. Boelens is a renowned clinical leader...